{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:46Z","timestamp":1786980526721,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10067-012-2022-4","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T12:14:14Z","timestamp":1340367254000},"page":"1347-1357","source":"Crossref","is-referenced-by-count":29,"title":["Effect of 12\u00a0months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI"],"prefix":"10.1007","volume":"31","author":[{"given":"J-J.","family":"Railhac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-S.","family":"Saurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fournie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,23]]},"reference":[{"key":"2022_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/ard.2004.022137","volume":"63","author":"JS Smolen","year":"2004","unstructured":"Smolen JS (2004) Combatting the burden of musculoskeletal conditions. Ann Rheum Dis 63:329","journal-title":"Ann Rheum Dis"},{"key":"2022_CR2","unstructured":"Report of a WHO Scientific Group (2003) The burden of musculoskeletal conditions at the start of the new millenium. WHO Technical Report Series, 919; Geneva"},{"key":"2022_CR3","first-page":"2271","volume":"33","author":"CF Dillon","year":"2006","unstructured":"Dillon CF, Rasch EK, Gu Q et al (2006) Prevalence of knee osteoarthritis in the United States: arthritis data from the third national Health and nutrition examination survey 1991\u20131994. J Rheumatol 33:2271\u20132279","journal-title":"J Rheumatol"},{"key":"2022_CR4","first-page":"331","volume-title":"Osteoarthritis clinical and experimental aspects","author":"J Pouchot","year":"1999","unstructured":"Pouchot J, Coste J, Guillemin F (1999) Impact of osteoarthritis on quality of life. In: Reginster JY, Pelletier JP, Martel-Pelletier J, Henrotin Y (eds) Osteoarthritis clinical and experimental aspects. Heidelberg, Berlin, pp 331\u2013355"},{"key":"2022_CR5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","volume":"43","author":"RD Altman","year":"2000","unstructured":"Altman RD, Hochberg MC, Moskowitz RW et al (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 Update. Arthritis Rheum 43:1905\u20131915","journal-title":"Arthritis Rheum"},{"key":"2022_CR6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M et al (2003) EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62:1145\u20131155","journal-title":"Ann Rheum Dis"},{"key":"2022_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16:137\u2013162","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW et al (2010) OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 18:476\u2013499","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/sarh.2000.24874","volume":"31","author":"JP Bali","year":"2001","unstructured":"Bali JP, Cousse H, Neuzil E (2001) Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system. Semin Arthritis Rheum 31:58\u201368","journal-title":"Semin Arthritis Rheum"},{"key":"2022_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ab.2007.11.006","volume":"374","author":"CJ Malavaki","year":"2008","unstructured":"Malavaki CJ, Asimakopoulou AP, Lamari FN et al (2008) Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations. Anal Biochem 374:213\u2013220","journal-title":"Anal Biochem"},{"key":"2022_CR11","first-page":"1385","volume":"23","author":"P Morreale","year":"1996","unstructured":"Morreale P, Manopulo R, Galati M et al (1996) Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee ostoarthritis. J Rheumatol 23:1385\u20131391","journal-title":"J Rheumatol"},{"issue":"Suppl A","key":"2022_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1063-4584(98)80008-3","volume":"6","author":"P Bourgeois","year":"1998","unstructured":"Bourgeois P, Chales G, Dehais J et al (1998) Efficacy and tolerability of chondroitin sulfate 1200\u00a0mg\/day vs chondroitin sulfate 3\u2009\u00d7\u2009400\u00a0mg\/day vs placebo. Osteoarthr Cartil 6(Suppl A):25\u201330","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl A","key":"2022_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1063-4584(98)80009-5","volume":"6","author":"L Bucsi","year":"1998","unstructured":"Bucsi L, Poor G (1998) Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SySADOA) in the treatment of knee osteoarthritis. Osteoarthr Cartil 6(Suppl A):31\u201336","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl A","key":"2022_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1063-4584(98)80011-3","volume":"6","author":"D Uebelhart","year":"1998","unstructured":"Uebelhart D, Thonar EJM, Delmas PD et al (1998) Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthr Cartil 6(Suppl A):39\u201346","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","volume":"12","author":"D Uebelhart","year":"2004","unstructured":"Uebelhart D, Malaise M, Marcolongo M et al (2004) Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomised, double-blind, multicenter study versus placebo. Osteoarthr Cartil 12:269\u2013276","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"2022_CR16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.20867","volume":"52","author":"BA Michel","year":"2005","unstructured":"Michel BA, Stucki G, Frey D et al (2005) Chondroitins 4 and 6 sulfate in osteoarthritis of the knee. A randomized controlled trial. Arthritis Rheum 52(3):779\u2013786","journal-title":"Arthritis Rheum"},{"key":"2022_CR17","first-page":"466","volume":"59","author":"B Mazi\u00e8res","year":"1992","unstructured":"Mazi\u00e8res B, Loyau G, Menk\u00e8s CJ et al (1992) Le chondro\u00eftine sulfate dans le traitement de la gonarthrose et de la coxarthrose. Rev Rhum 59:466\u2013472","journal-title":"Rev Rhum"},{"key":"2022_CR18","first-page":"173","volume":"28","author":"B Mazi\u00e8res","year":"2001","unstructured":"Mazi\u00e8res B, Combe B, Van Phan A et al (2001) Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo-controlled multicenter clinical study. J Rheumatol 28:173\u2013181","journal-title":"J Rheumatol"},{"key":"2022_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/ard.2006.059899","volume":"66","author":"B Mazi\u00e8res","year":"2007","unstructured":"Mazi\u00e8res B, Hucher M, Za\u00efm M et al (2007) Effect of chondroitin sulfate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 66:639\u2013645","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2022_CR20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"D Clegg","year":"2006","unstructured":"Clegg D, Reda DJ, Harris CL et al (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354(8):795\u2013808","journal-title":"N Engl J Med"},{"key":"2022_CR21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","volume":"60","author":"A Kahan","year":"2009","unstructured":"Kahan A, Uebelhardt D, De Vathaire F et al (2009) Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 60:524\u2013533","journal-title":"Arthritis Rheum"},{"key":"2022_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yrtph.2006.07.004","volume":"47","author":"JN Hathcock","year":"2007","unstructured":"Hathcock JN, Shao A (2007) Risk assessment for glucosamine and chondroitin sulfate. Regul Toxicol Pharmacol 47:78\u201383","journal-title":"Regul Toxicol Pharmacol"},{"key":"2022_CR23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","volume":"15","author":"TE McAlindon","year":"2000","unstructured":"McAlindon TE, La Valley MP, Gulin JP et al (2000) Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 15:1469\u20131475","journal-title":"JAMA"},{"key":"2022_CR24","first-page":"205","volume":"24","author":"B Leeb","year":"2000","unstructured":"Leeb B, Sweitzer H, Montag K et al (2000) A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 24:205\u2013211","journal-title":"J Rheumatol"},{"key":"2022_CR25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.163.13.1514","volume":"163","author":"F Richy","year":"2003","unstructured":"Richy F, Bruyere O, Ethgen O et al (2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Arch Intern Med 163:1514\u20131522","journal-title":"Arch Intern Med"},{"key":"2022_CR26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-146-8-200704170-00009","volume":"146","author":"S Reichenbach","year":"2007","unstructured":"Reichenbach S, Sterchi R, Scherer M et al (2007) Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146:580\u2013590","journal-title":"Ann Intern Med"},{"key":"2022_CR27","doi-asserted-by":"crossref","unstructured":"Wandel S, J\u00fcni P, Tendal B, et al. (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341: c4675. Published online on 16 September 2010. http:\/\/www.bmj.com\/content\/341\/bmj.c4675.long","DOI":"10.1136\/bmj.c4675"},{"key":"2022_CR28","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.joca.2008.06.006","volume":"16","author":"D Uebelhart","year":"2008","unstructured":"Uebelhart D (2008) Clinical review of chondroitin sulfate in osteoarthritis. Osteoarthr Cartil 16:S19\u2013S21","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1054-3589(05)53026-6","volume":"53","author":"G Bana","year":"2006","unstructured":"Bana G, Jamard B, Verrouil E et al (2006) Chondroitin sulphate in the management of hip and knee osteoarthritis: an overview. Adv Pharmacol 53:507\u2013522","journal-title":"Adv Pharmacol"},{"issue":"9","key":"2022_CR30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/ard.2004.021253","volume":"63","author":"FM Cicuttini","year":"2004","unstructured":"Cicuttini FM, Jones G, Forbes A et al (2004) Rate of cartilage loss at 2\u00a0years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 63(9):1124\u20131127","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2022_CR31","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar1962","volume":"8","author":"AE Wluka","year":"2006","unstructured":"Wluka AE, Forbes A, Wang Y et al (2006) Knee cartilage loss in symptomatic knee osteoarthritis over 4.5\u00a0years. Arthritis Res Ther 8(4):R90","journal-title":"Arthritis Res Ther"},{"key":"2022_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/joca.1998.0165","volume":"7","author":"ZA Cohen","year":"1999","unstructured":"Cohen ZA, McCarthy DM, Kwak SD et al (1999) Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements. Osteoarthr Cartil 7:95\u2013109","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR33","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/1529-0131(200109)44:9<2072::AID-ART357>3.0.CO;2-3","volume":"44","author":"R Burgkart","year":"2001","unstructured":"Burgkart R, Glaser C, Hyhlik-Durr A et al (2001) Magnetic resonance imaging-based assessment of cartilage loss in severe osteoarthritis: accuracy, precision, and diagnostic value. Arthritis Rheum 44:2072\u20132077","journal-title":"Arthritis Rheum"},{"key":"2022_CR34","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/art.10460","volume":"46","author":"AE Wluka","year":"2002","unstructured":"Wluka AE, Stuckey S, Snaddon J et al (2002) The determinants of change in tibial cartilage volume in osteoarthritic knees. Arthritis Rheum 46:2065\u20132072","journal-title":"Arthritis Rheum"},{"key":"2022_CR35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/ard.60.10.977","volume":"60","author":"FM Cicuttini","year":"2001","unstructured":"Cicuttini FM, Wluka AE, Stuckey SL (2001) Tibial and femoral cartilage changes in knee osteoarthritis. Ann Rheum Dis 60:977\u2013980","journal-title":"Ann Rheum Dis"},{"key":"2022_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1063-4584(03)00029-3","volume":"11","author":"JP Raynauld","year":"2003","unstructured":"Raynauld JP, Kauffmann C, Beaudoin G et al (2003) Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthr Cartil 11:351\u2013360","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR37","first-page":"S150","volume":"46","author":"JP Raynauld","year":"2002","unstructured":"Raynauld JP, Pelletier JP, Beaudoin G et al (2002) A two-year study in osteoarthritis patients following the progression of the disease by magnetic resonance imaging using a novel quantification imaging system [abstract]. Arthritis Rheum 46:S150","journal-title":"Arthritis Rheum"},{"issue":"Suppl A","key":"2022_CR38","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.joca.2003.09.011","volume":"12","author":"RD Altman","year":"2004","unstructured":"Altman RD (2004) Measurement of structure (disease) modification in osteoarthritis. Osteoarthr Cartil 12(Suppl A):S69\u2013S76","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"2022_CR39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.berh.2005.08.003","volume":"20","author":"P Conaghan","year":"2006","unstructured":"Conaghan P (2006) Is MRI useful in osteoarthritis? Best Pract Res Clin Rheumatol 20(1):57\u201368","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"4","key":"2022_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.joca.2004.01.006","volume":"12","author":"E Abadie","year":"2004","unstructured":"Abadie E, Ethgen D, Avouac B et al (2004) Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthr Cartil 12(4):263\u2013268","journal-title":"Osteoarthr Cartil"},{"key":"2022_CR41","unstructured":"European Medicines Agency (EMA). Committee for Medicinal Products for Human use (CHMP). Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. 20 January 2010. CPMP\/EWP\/784\/97 Rev. 1. http:\/\/www.tga.gov.au\/pdf\/euguide\/ewp078497en.pdf . Accessed 21-May-2012"},{"key":"2022_CR42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum 29:1039\u20131049","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"2022_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","volume":"65","author":"M Lequesne","year":"1987","unstructured":"Lequesne M, M\u00e9ry C, Samson M et al (1987) Indexes of severity for osteoarthritis of the hip and knee. Scand J Rheumatol 65(Suppl):85\u201389","journal-title":"Scand J Rheumatol"},{"key":"2022_CR44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JK Kellgren","year":"1957","unstructured":"Kellgren JK, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:494\u2013501","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2022_CR45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiol.2262012190","volume":"226","author":"TM Link","year":"2003","unstructured":"Link TM, Steinbach LS, Ghosh S et al (2003) Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology 226(2):373\u2013381","journal-title":"Radiology"},{"issue":"6","key":"2022_CR46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ard.2010.140848","volume":"70","author":"LM Wildi","year":"2011","unstructured":"Wildi LM, Raynauld JP, Martel-Pelletier J et al (2011) Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6\u00a0months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 70(6):982\u2013989","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2022_CR47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00002512-200724070-00005","volume":"24","author":"O Bruyere","year":"2007","unstructured":"Bruyere O, Reginster JY (2007) Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 24(7):573\u2013580","journal-title":"Drugs Aging"},{"issue":"Suppl 1","key":"2022_CR48","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.joca.2010.02.016","volume":"18","author":"MC Hochberg","year":"2010","unstructured":"Hochberg MC (2010) Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthr Cartil 18(Suppl 1):S28\u2013S31","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl 1","key":"2022_CR49","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.joca.2010.01.015","volume":"18","author":"J Martel-Pelletier","year":"2010","unstructured":"Martel-Pelletier J, Kwan Tat S et al (2010) Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthr Cartil 18(Suppl 1):S7\u2013S11","journal-title":"Osteoarthr Cartil"},{"issue":"52","key":"2022_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13520","volume":"13","author":"C Black","year":"2009","unstructured":"Black C, Clar C, Henderson R et al (2009) The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 13(52):1\u2013148","journal-title":"Health Technol Assess"},{"issue":"Suppl A","key":"2022_CR51","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/j.joca.2006.02.028","volume":"14","author":"PG Conaghan","year":"2006","unstructured":"Conaghan PG, Felson D, Gold G et al (2006) MRI and non-cartilaginous structures in knee osteoarthritis. Osteoarthr Cartil 14(Suppl A):A87\u2013A94","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"2022_CR52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/ard.2008.088732","volume":"68","author":"JP Raynauld","year":"2009","unstructured":"Raynauld JP, Martel-Pelletier J, Bias P et al (2009) Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 68(6):938\u2013947","journal-title":"Ann Rheum Dis"},{"issue":"Suppl A","key":"2022_CR53","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1016\/j.joca.2006.02.026","volume":"14","author":"F Eckstein","year":"2006","unstructured":"Eckstein F, Cicuttini F, Raynauld JP et al (2006) Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthr Cartil 14(Suppl A):A46\u2013A75","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"2022_CR54","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/ar1875","volume":"8","author":"JP Raynauld","year":"2006","unstructured":"Raynauld JP, Martel-Pelletier J, Berthiaume MJ et al (2006) Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 8(1):R21","journal-title":"Arthritis Res Ther"}],"updated-by":[{"DOI":"10.1007\/s10067-014-2724-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T00:00:00Z","timestamp":1403222400000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2022-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2022-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:55Z","timestamp":1559105515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2022-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,23]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2022-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,23]]}}}